KLI
CVS icon

Kelman-Lazarov Inc’s CVS Health CVS Stock Holding History

Kelman-Lazarov Inc’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,154
Closed -$332K – 95
2019
Q1 		$332K Sell
6,154
-16,199
-72% -$1,000K 0.18% 76
2018
Q4 		$1.47M Sell
22,353
-6,246
-22% -$466K 0.91% 25
2018
Q3 		$2.25M Sell
28,599
-5,052
-15% -$361K 1.32% 22
2018
Q2 		$2.17M Sell
33,651
-2,623
-7% -$173K 1.16% 27
2018
Q1 		$2.26M Sell
36,274
-1,597
-4% -$115K 1.21% 27
2017
Q4 		$2.75M Sell
37,871
-1,683
-4% -$122K 1.4% 22
2017
Q3 		$3.22M Buy
39,554
+1,715
+5% +$136K 1.7% 17
2017
Q2 		$3.04M Buy
+37,839
New +$2.99M 1.67% 20
2017
Q1 		– Sell
-264
Closed -$20.8K – 134
2016
Q4 		$20.8K Hold
264
– – 0.01% 218
2016
Q3 		$22.8K Buy
+264
New +$24.9K 0.01% 242

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kelman-Lazarov Inc's CVS Position: Q2 2019 in Review

Kelman-Lazarov Inc sold out of CVS Health (CVS) in Q2 2019, closing a stake of 6,154 shares — an estimated $332K sold.

Kelman-Lazarov Inc first reported a position in CVS in Q3 2016 and held it in 10 quarters. The position peaked at $3.22M in Q3 2017. 1,654 funds tracked by Wall St. Rank hold CVS as of Q2 2019.

  • Kelman-Lazarov Inc reported no remaining CVS Health position as of Q2 2019 after selling out during the quarter.
  • Kelman-Lazarov Inc sold 6,154 CVS Health shares in Q2 2019, an estimated $332K.
  • Kelman-Lazarov Inc first reported a position in CVS Health in Q3 2016 and held it in 10 quarters.
  • Kelman-Lazarov Inc's CVS Health position peaked at $3.22M in Q3 2017.
  • 1,654 funds tracked by Wall St. Rank held CVS Health as of Q2 2019.

Based on Kelman-Lazarov Inc's 13F filing for Q2 2019, filed 22 Jul 2019.